Navigation Links
Wyeth Names Daniel J. McIntyre Vice President, Corporate Communications
Date:9/3/2008

MADISON, N.J., Sept. 3 /PRNewswire-FirstCall/ -- Wyeth (NYSE: WYE) today announced the appointment of Daniel J. McIntyre, 54, to Vice President, Corporate Communications. Reporting to Timothy P. Cost, Senior Vice President, Corporate Affairs, Mr. McIntyre will be responsible for all internal and external communications for the corporation and its three major divisions -- pharmaceuticals, consumer health care and animal health -- around the world.

Prior to joining Wyeth, Mr. McIntyre held a series of senior executive positions in communications and health care. Most recently, he was Managing Director of the healthcare practice of Fleishman-Hillard International Communications. He previously served in senior level Communications and Public Policy positions for Pharmacia Corporation, Bayer Corporation's Pharmaceutical Division, the Bristol-Myers Squibb Company, and Hoffmann-La Roche Inc.

"Wyeth is in one of the most important periods in its history," says Mr. Cost. "We are building momentum toward developing new therapies for patients even as we transform our organization for the future. Having Dan now leading our communications team is an important part of our plan to meet new and evolving challenges."

An honors graduate of Seton Hall University, McIntyre holds an MPA from Rutgers University. He is a member of the executive committee of the Rutgers University Foundation, and has served on the boards of trustees of Caldwell College, the American Association for World Health, the New England Healthcare Institute (NEHI) and Connecticut United for Research Excellence (CURE). He is also a member of the Public Relations Society of America (PRSA).

Wyeth is one of the world's largest research-driven pharmaceutical and health care products companies. It is a leader in the discovery, development, manufacturing and marketing of pharmaceuticals, vaccines, biotechnology products, nutritionals and non-prescription medicines that improve the quality of life for people worldwide. The Company's major divisions include Wyeth Pharmaceuticals, Wyeth Consumer Healthcare and Fort Dodge Animal Health.


'/>"/>
SOURCE Wyeth
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Wyeth and Impax Announce Final Settlement of Effexor XR Patent Suit
2. Wyeths Motion to Overturn Punitive Damages Award Granted by Arkansas Court
3. Wyeth Announces Bernard Poussot Assumes Chairman of the Board Position
4. Wyeth Declares Common and Preferred Stock Dividends
5. Wyeth Pharmaceuticals Announces Organizational Change
6. Intellect Neurosciences, Inc. Grants License for Certain Patents and Patent Applications to Wyeth and Elan Pharma International Ltd.
7. Wyeth to Present at the 2008 Citi Investment Research Global Healthcare Conference
8. Wyeth Research Head Robert R. Ruffolo, Jr., Ph.D., Announces Retirement
9. Wyeth Chairman Robert Essner Announces June 27 Retirement
10. Wyeth and Progenics Receive Positive Opinion From European Committee for RELISTOR for the Treatment of Opioid-Induced Constipation in Advanced-Illness Patients
11. Wyeth to Present at the Lehman Brothers Eleventh Annual Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/3/2016)... ... May 03, 2016 , ... ... clinics and IVF laboratories. A contingency of reproductive endocrinologists, including Dr. George ... women experiencing infertility and to help them build families. , Ovation Fertility is ...
(Date:5/2/2016)... CA (PRWEB) , ... May 02, 2016 , ... StarNet ... solutions today announced the addition of three Secure Remote Desktop modules to its flagship ... remote desktops from Linux and Unix servers to the user’s PC over encrypted SSH. ...
(Date:4/29/2016)... ... April 29, 2016 , ... Proove ... excited to announce the launch of the Proove Health Foundation . The ... education to promote the use of personalized medicine for tackling the nation’s most-pressing ...
(Date:4/29/2016)... CO (PRWEB) , ... April 29, 2016 , ... ... addressing the necessary fundamentals to transform technology into a viable company, CereScan’s CEO, ... growth. Mr. Kelley, a recognized leader and mentor in the Denver area ...
Breaking Biology Technology:
(Date:3/11/2016)... -- --> --> ... Market by Technology (Pattern Recognition), by Component (Hardware, Software, ... (On-Premises and Cloud), by Industry Vertical and by Region ... global market is expected to grow from USD 12.49 ... at a CAGR of 19.1%. , ...
(Date:3/9/2016)... This BCC Research report provides an overview ... Sequencing (RNA Seq) market for the years 2015, 2016 ... reagents, data analysis, and services. Use this ... market such as RNA-Sequencing tools and reagents, RNA-Sequencing data ... each segment and forecast their market growth, future trends ...
(Date:3/8/2016)...   Valencell , the leading innovator in ... secured $11M in Series D financing. The investment ... fund being launched by UAE-based financial services company ... TDF Ventures and WSJ Joshua Fund. Valencell plans ... growth and accelerate its pioneering innovation in accurate ...
Breaking Biology News(10 mins):